Clinical trial
Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive…
NCT00036309 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00036309 |
|---|---|
| Title | Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder |
| Official title | Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Depressive Disorder |
| Intervention type | Drug |
| Interventions | Duloxetine Hydrochloride |
| Start date | May 1, 2002 |
| Completion | Jul 1, 2003 |
| First posted | May 9, 2002 |
| Last update posted | Jul 19, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: